Table 3.
Estimated incidence of all (first and recurrent) psychiatric diagnoses during the first 14 to 90 days after a diagnosis of COVID-19 compared with other health events
|
COVID-19 |
Influenza |
Other respiratory tract infection |
Skin infection |
Cholelithiasis |
Urolithiasis |
Fracture |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % (95% CI) | % (95% CI) | p value | % (95% CI) | p value | % (95% CI) | p value | % (95% CI) | p value | % (95% CI) | p value | % (95% CI) | p value | ||
| Psychiatric illness | 18·1 (17·6–18·6) | 13·3 (12·8–13·7) | <0·0001 | 14·1 (13·8–14·5) | <0·0001 | 14·8 (14·4–15·2) | <0·0001 | 15·1 (14·6–15·6) | <0·0001 | 13·7 (13·3–14·1) | <0·0001 | 12·7 (12·4–13·1) | <0·0001 | |
| Psychotic disorder | 0·94 (0·82–1·1) | 0·49 (0·41–0·59) | <0·0001 | 0·60 (0·53–0·70) | <0·0001 | 0·92 (0·82–1·0) | 0·44 | 0·72 (0·61–0·86) | 0·045 | 0·44 (0·37–0·53) | <0·0001 | 0·74 (0·65–0·84) | 0·034 | |
| Mood disorder | 9·9 (9·5–10·3) | 7·4 (7·1–7·8) | <0·0001 | 7·6 (7·3–7·9) | <0·0001 | 8·6 (8·3–9·0) | <0·0001 | 9·2 (8·8–9·7) | <0·0001 | 8·3 (8·0–8·6) | <0·0001 | 8·1 (7·8–8·4) | <0·0001 | |
| Anxiety disorder | 12·8 (12·4–13·3) | 9·4 (9·0–9·8) | <0·0001 | 10·1 (9·8–10·5) | <0·0001 | 10·0 (9·6–10·4) | <0·0001 | 10·0 (9·6–10·5) | <0·0001 | 9·5 (9·2–9·9) | <0·0001 | 7·9 (7·6–8·3) | <0·0001 | |